These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18814025)

  • 1. L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; de Mari JF; Barden AT; Vanzin CS; Biancini GB; Schwartz IV; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2009 Mar; 29(2):211-8. PubMed ID: 18814025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients.
    Sitta A; Vanzin CS; Biancini GB; Manfredini V; de Oliveira AB; Wayhs CA; Ribas GO; Giugliani L; Schwartz IV; Bohrer D; Garcia SC; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2011 Apr; 31(3):429-36. PubMed ID: 21191647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
    Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I
    Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of oxidative stress parameters in treated phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; Terroso T; Pires R; Giugliani R; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2006 Dec; 21(4):287-96. PubMed ID: 17146735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic Markers of Essential Fatty Acids, Carnitine, and Cholesterol Metabolism in Adults and Adolescents with Phenylketonuria.
    Stroup BM; Nair N; Murali SG; Broniowska K; Rohr F; Levy HL; Ney DM
    J Nutr; 2018 Feb; 148(2):194-201. PubMed ID: 29490096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in patients with phenylketonuria.
    Sirtori LR; Dutra-Filho CS; Fitarelli D; Sitta A; Haeser A; Barschak AG; Wajner M; Coelho DM; Llesuy S; Belló-Klein A; Giugliani R; Deon M; Vargas CR
    Biochim Biophys Acta; 2005 Apr; 1740(1):68-73. PubMed ID: 15878743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased peripheral of brain-derived neurotrophic factor levels in phenylketonuric patients treated with l-carnitine.
    Faverzani JL; Guerreiro G; Hammerschmidt TG; Lopes FF; Coelho DM; Sitta A; Mescka CP; Deon M; Wajner M; Vargas CR
    Arch Biochem Biophys; 2023 Nov; 749():109792. PubMed ID: 37863349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled diet in phenylketonuria may cause serum carnitine deficiency.
    Vilaseca MA; Briones P; Ferrer I; Campistol J; Riverola A; Castillo P; Ramon F
    J Inherit Metab Dis; 1993; 16(1):101-4. PubMed ID: 8487489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of L-carnitine on Phenylalanine-induced DNA damage.
    Deon M; Landgraf SS; Lamberty JF; Moura DJ; Saffi J; Wajner M; Vargas CR
    Metab Brain Dis; 2015 Aug; 30(4):925-33. PubMed ID: 25600689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum carnitine level in phenylketonuric children under dietary control in Greece.
    Schulpis KH; Nounopoulos C; Scarpalezou A; Bouloukos A; Missiou-Tsagarakis S
    Acta Paediatr Scand; 1990 Oct; 79(10):930-4. PubMed ID: 2264465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patients.
    Deon M; Sitta A; Faverzani JL; Guerreiro GB; Donida B; Marchetti DP; Mescka CP; Ribas GS; Coitinho AS; Wajner M; Vargas CR
    Int J Dev Neurosci; 2015 Dec; 47(Pt B):259-65. PubMed ID: 26456498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients.
    Sitta A; Manfredini V; Biasi L; Treméa R; Schwartz IV; Wajner M; Vargas CR
    Mutat Res; 2009; 679(1-2):13-6. PubMed ID: 19665577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studying the effect of large neutral amino acid supplements on oxidative stress in phenylketonuric patients.
    Kumru B; Ozturk Hismi B; Kaplan DS; Celik H
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):269-274. PubMed ID: 30835252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-carnitine protects DNA oxidative damage induced by phenylalanine and its keto acid derivatives in neural cells: a possible pathomechanism and adjuvant therapy for brain injury in phenylketonuria.
    Faverzani JL; Steinmetz A; Deon M; Marchetti DP; Guerreiro G; Sitta A; de Moura Coelho D; Lopes FF; Nascimento LVM; Steffens L; Henn JG; Ferro MB; Brito VB; Wajner M; Moura DJ; Vargas CR
    Metab Brain Dis; 2021 Oct; 36(7):1957-1968. PubMed ID: 34216350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders.
    Ribas GS; Vargas CR; Wajner M
    Gene; 2014 Jan; 533(2):469-76. PubMed ID: 24148561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylketonuric diet negatively impacts on butyrate production.
    Verduci E; Moretti F; Bassanini G; Banderali G; Rovelli V; Casiraghi MC; Morace G; Borgo F; Borghi E
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):385-392. PubMed ID: 29502926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of diet on plasma total antioxidant status in phenylketonuric patients.
    Schulpis KH; Tsakiris S; Karikas GA; Moukas M; Behrakis P
    Eur J Clin Nutr; 2003 Feb; 57(2):383-7. PubMed ID: 12571675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress in phenylketonuria: future directions.
    Rocha JC; Martins MJ
    J Inherit Metab Dis; 2012 May; 35(3):381-98. PubMed ID: 22116469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Blood Phenylalanine Levels on Oxidative Stress in Classical Phenylketonuric Patients.
    Kumru B; Kaplan DS; Oztürk Hismi B; Celik H
    Cell Mol Neurobiol; 2018 Jul; 38(5):1033-1038. PubMed ID: 29285660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cytokine levels induced by high phenylalanine concentrations in late diagnosis PKU patients compared to early diagnosis: Anti-inflammatory effect of L-carnitine.
    Faverzani JL; Hammerschmidt TG; Mescka CP; Guerreiro G; Lopes FF; Delgado CA; de Moura Coelho D; Sitta A; Deon M; Wajner M; Vargas CR
    Cell Biochem Funct; 2023 Jun; 41(4):490-500. PubMed ID: 37170672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.